16.2.5 Compliance And/Or Drug Concentration Data

16.2.5 Compliance And/Or Drug Concentration Data

Clinical Study Report Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 16.2.5 Compliance and/or Drug Concentration Data Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 1 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1001 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 4 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 4 R1002 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 R1003 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 2 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1004 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 3 1.0 g of snus or placebo logs dispensed 3 Week 10 0.5 g of snus or placebo logs dispensed 6 1.0 g of snus or placebo logs dispensed 0 R1005 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 4 1.0 g of snus or placebo logs dispensed 2 Week 10 0.5 g of snus or placebo logs dispensed 5 1.0 g of snus or placebo logs dispensed 2 R1006 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 3 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1006 Week 6 0.5 g of snus or placebo logs dispensed 3 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 R1007 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 3 1.0 g of snus or placebo logs dispensed 0 R1008 Week 0 0.5 g of snus or placebo logs dispensed 10 1.0 g of snus or placebo logs dispensed 6 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 4 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1009 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 0 R1010 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 2 Week 10 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 4 R1011 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 5 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1011 Week 10 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 R1012 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 3 Week 10 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 5 R1013 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 3 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 3 1.0 g of snus or placebo logs dispensed 0 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 6 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1014 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 R1015 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 R1016 Week 0 0.5 g of snus or placebo logs dispensed 10 1.0 g of snus or placebo logs dispensed 6 Week 6 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 2 Week 10 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 2 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 7 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1017 Week 0 0.5 g of snus or placebo logs dispensed 08 1.0 g of snus or placebo logs dispensed 04 Week 6 0.5 g of snus or placebo logs dispensed 2 1.0 g of snus or placebo logs dispensed 0 Week 10 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 0 R1018 Week 0 0.5 g of snus or placebo logs dispensed 10 1.0 g of snus or placebo logs dispensed 06 Week 6 0.5 g of snus or placebo logs dispensed 1 1.0 g of snus or placebo logs dispensed 0 R1019 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 3 Clinical Study Report Confidential Covance CRU Study No. 7694-105 Sponsor Protocol No. SM 08-01 Listing 16.2.5-1 Product Dispensation by Subject (Page 8 of 86) Study Population: ITT Subject Amount Dispensed Number Timepoint Study product (logs) R1019 Week 10 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 3 R1020 Week 0 0.5 g of snus or placebo logs dispensed 8 1.0 g of snus or placebo logs dispensed 4 Week 6 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 2 Week 10 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 2 R1021 Week 0 0.5 g of snus or placebo logs dispensed 10 1.0 g of snus or placebo logs dispensed 6 Week 6 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 2 Week 10 0.5 g of snus or placebo logs dispensed 0 1.0 g of snus or placebo logs dispensed 3 Clinical Study Report Confidential Covance CRU Study No.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    457 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us